A detailed history of Gamma Investing LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 117 shares of ARCT stock, worth $1,997. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Previous 178 34.27%
Holding current value
$1,997
Previous $4.33 Million 37.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$18.08 - $25.38 $1,102 - $1,548
-61 Reduced 34.27%
117 $2.72 Million
Q2 2024

Jul 02, 2024

BUY
$24.35 - $44.39 $3,019 - $5,504
124 Added 229.63%
178 $4.33 Million
Q1 2024

Apr 05, 2024

BUY
$31.23 - $42.99 $156 - $214
5 Added 10.2%
54 $1.82 Million
Q4 2023

Feb 01, 2024

BUY
$17.71 - $32.97 $867 - $1,615
49 New
49 $1.62 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $454M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.